Skip to main content
. Author manuscript; available in PMC: 2022 Nov 14.
Published in final edited form as: Expert Opin Ther Pat. 2019 Jun 16;29(7):555–578. doi: 10.1080/13543776.2019.1630379

Table 3.

Examples of representative imidazolone (12–17) and pyrazolone derivatives (18, 19) developed by Chiesi Farmaceutici S.p.A.

graphic file with name nihms-1847152-t0009.jpg
Compound R1 R2 IC50 (nM)a Reference
12 graphic file with name nihms-1847152-t0010.jpg H < 1 [143]
13 graphic file with name nihms-1847152-t0011.jpg H < 1 [143]
14 graphic file with name nihms-1847152-t0012.jpg H < 1 [143]
15 graphic file with name nihms-1847152-t0013.jpg H < 1 [143]
16 graphic file with name nihms-1847152-t0014.jpg graphic file with name nihms-1847152-t0015.jpg < 1 [144]
17 graphic file with name nihms-1847152-t0016.jpg graphic file with name nihms-1847152-t0017.jpg < 1 [144]
18 graphic file with name nihms-1847152-t0018.jpg graphic file with name nihms-1847152-t0019.jpg < 1 [144]
19 graphic file with name nihms-1847152-t0020.jpg graphic file with name nihms-1847152-t0021.jpg < 1 [144]
a

The results are means of two independent experiments, each performed in duplicate (HNE enzyme assay).